Using Radiomics and Machine Learning Applied to MRI to Predict Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer
Authors:
- Valentina ChiappaVCValentina Chiappa
- Giorgio BoganiGBGiorgio Bogani
- Matteo InterlenghiMatteo Interlenghi
- Giulia Vittori AntisariGAGiulia Vittori Antisari
- Christian SalvatoreCSChristian Salvatore
- Lucia ZanchiLZLucia Zanchi
- Manuela LudovisiManuela Ludovisi
- Umberto Leone Roberti MaggioreUMUmberto Leone Roberti Maggiore
- Giuseppina CalaresoGCGiuseppina Calareso
- Edward HaeuslerEHEdward Haeusler
- Francesco RaspagliesiFRFrancesco Raspagliesi
- Isabella CastiglioniICIsabella Castiglioni
Open Access
- 6 October 2023
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 13 (19) , 3139
Abstract
Neoadjuvant chemotherapy plus radical surgery could be a safe alternative to chemo-radiation in cervical cancer patients who are not willing to receive radiotherapy. The response to neoadjuvant chemotherapy is the main factor influencing the need for adjunctive treatments and survival. In the present paper we aim to develop a machine learning model based on cervix magnetic resonance imaging (MRI) images to stratify the single-subject risk of cervical cancer. We collected MRI images from 72 subjects. Among these subjects, 28 patients (38.9%) belonged to the “Not completely responding” class and 44 patients (61.1%) belonged to the ’Completely responding‘ class according to their response to treatment. This image set was used for the training and cross-validation of different machine learning models. A robust radiomic approach was applied, under the hypothesis that the radiomic features could be able to capture the disease heterogeneity among the two groups. Three models consisting of three ensembles of machine learning classifiers (random forests, support vector machines, and k-nearest neighbor classifiers) were developed for the binary classification task of interest (“Not completely responding” vs. “Completely responding”), based on supervised learning, using response to treatment as the reference standard. The best model showed an ROC-AUC (%) of 83 (majority vote), 82.3 (mean) [79.9–84.6], an accuracy (%) of 74, 74.1 [72.1–76.1], a sensitivity (%) of 71, 73.8 [68.7–78.9], and a specificity (%) of 75, 74.2 [71–77.5]. In conclusion, our preliminary data support the adoption of a radiomic-based approach to predict the response to neoadjuvant chemotherapy.Keywords
This publication has 29 references indexed in Scilit:
- Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapyJournal of Magnetic Resonance Imaging, 2017
- Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After ChemoradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2017
- The Potential of Radiomic-Based Phenotyping in Precision MedicineJAMA Oncology, 2016
- Declining Rates of High-Grade Cervical Lesions in Young Women in Connecticut, 2008–2011Cancer Epidemiology, Biomarkers & Prevention, 2013
- Temporal analysis of intratumoral metabolic heterogeneity characterized by textural features in cervical cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Comparison Between Conventional Surgery Plus Postoperative Adjuvant Radiotherapy and Concurrent Chemoradiation for FIGO Stage IIB Cervical CarcinomaAmerican Journal of Clinical Oncology, 2010
- A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: Follow-up of a gynecologic oncology group studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapyGynecologic Oncology, 2004
- Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the CervixJournal of Clinical Oncology, 2000
- Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group studyGynecologic Oncology, 1990